DeSimone Jill
- SEC CIK
- 0001930479
In the past year, 1 open-market sale filing worth $3.61M and no purchases.
Current role at each company
- PRAX Praxis Precision Medicines, Inc.Directoras of Jun 26, 2026
- ONCT Oncternal Therapeutics, Inc.Directoras of Jun 24, 2024
- ITOS iTeos Therapeutics, Inc.Directoras of Jun 13, 2024
- KNTE Kinnate Biopharma Inc.Directoras of Apr 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.61M
- 1 filing
- Net
- −$3.61M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists DeSimone Jill as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PRAX Praxis Precision Medicines, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 (view filing) | Jun 24 | 2 days | DeSimone JillDirector | SSale | −11.6K | $311.32 | −$3.61M | −83.2%2.34K after | 12 lots10b5-1 |
| Oct 10, 2023 (view filing) | Oct 5 | 5 days | DeSimone JillDirector | PPurchase | +14.5K | $1.75 | +$25.4K | New position14.5K after |